Medication info
Hallym Sitagliptin Tablet 25 mg (Sitagliptin Hydrochloride Monohydrate)

Hallym Sitagliptin Tablet 25 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›28.35mg / 1 tablet
Manufacturer / importer
Hallym Pharmaceutical Co., Ltd.
Appearance
Pink round, biconvex film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP × 3]
Approval status
Active

MFDS item code 202004063 · Approved 2020.05.29 · Insurance code 645306390

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For monotherapy or combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, section 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Hallym Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty in blood sugar control
View approved original text

This medication is used to assist in the blood sugar control of patients with type 2 diabetes. It can be administered alone while accompanying dietary and exercise therapy, and it can also be applied to patients with no prior experience in diabetes drug therapy. If blood sugar control is difficult with monotherapy, it may be co-administered with Metformin. Additionally, this medication is used together with other treatments such as sulfonylureas, thiazolidinediones, or insulin when adequate blood sugar control is not achieved. This medication is also added to enhance blood sugar control when the effect is insufficient with multiple drug regimens. It is used to improve overall blood sugar management.

How to take

Adult dose

For monotherapy or combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin (see Precautions for Use, section 5. General Precautions). Patients with renal impairment Because dosage adjustment according to renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may cause severe allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur after taking the medication, it should be discontinued immediately and a doctor consulted. There is a risk of serious inflammation of the pancreas called pancreatitis occurring during the use of this medication, so if symptoms such as abdominal pain, vomiting, or loss of appetite arise, one should immediately inform healthcare professionals. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and it must not be administered to those allergic to this medication or its ingredients. Patients with impaired kidney function need to adjust the dosage of this medication, and it is necessary to regularly monitor kidney function and take the medication according to a doctor's instructions. There may be side effects such as upper respiratory infections, headaches, dyspepsia, diarrhea, and hypoglycemia during the use of this medication, thus careful blood sugar management is necessary. Particularly when taken with insulin or sulfonylurea medications, the risk of hypoglycemia increases, so dosage adjustments may be required when necessary. If severe joint pain or symptoms such as blisters on the skin occur, one should inform a doctor immediately, and if these symptoms are suspected, medication discontinuation is advised. It is better for women who are pregnant or breastfeeding not to use this medication, and it is not administered to children or adolescents under 18 years old because its safety and efficacy have not been verified. Elderly patients may have reduced kidney function; thus, it is necessary to carefully monitor kidney function before and after taking this medication. In case of overdose, drug removal from the gastrointestinal tract and necessary monitoring like an electrocardiogram should be conducted, as some removal through hemodialysis is possible, so treatment should be followed according to healthcare professionals' instructions. This medication has relatively few drug interactions; however, caution is needed when taken with cyclosporine or digoxin, and consultation with a doctor is required before use.

Side effects

  • Hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative skin disease
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
Show 30 more
  • diarrhea
  • abdominal pain
  • nausea
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • vesicular pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • indigestion
  • dizziness
  • increased blood triglycerides
  • gastritis
  • severe hypoglycemia
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. The storage temperature should be maintained between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pink round, biconvex film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP × 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.